Specifications
Immunogen
Recombinant fragment within Human DGAT1 aa 1-100 (N terminal). The exact sequence is proprietary.Database link: O75907
Applications
Application Notes
ICC/IF: 1/50 - 1/100; IP: 1/30 - 1/50; Flow Cyt: 1/70; WB: 1/10000 - 1/50000.
Target
Alternative Names
DGAT1; diacylglycerol O-acyltransferase 1; diacylglycerol O acyltransferase homolog 1 (mouse); ARGP1; DGAT; ACAT related gene product 1; ACAT-related gene product 1; diglyceride acyltransferase; diacylglycerol O-acyltransferase homolog 1; acyl coenzyme A:
Product Background
Antigen Description
Catalyzes the terminal and only committed step in triacylglycerol synthesis by using diacylglycerol and fatty acyl CoA as substrates. In contrast to DGAT2 it is not essential for survival. May be involved in VLDL (very low density lipoprotein) assembly.
Pathway
Fat digestion and absorption, organism-specific biosystem; Fat digestion and absorption, conserved biosystem; Fatty acid, triacylglycerol, and ketone body metabolism, organism-specific biosystem; Glycerolipid metabolism, organism-specific biosystem; Glycerolipid metabolism, conserved biosystem; Metabolic pathways, organism-specific biosystem; Metabolism, organism-specific biosystem;
Citations
Publication ()
Have you cited DCABH-7158 in a publication?
Let us know and earn a reward for your research.